221 related articles for article (PubMed ID: 24913913)
1. Quantifying the risk of incompatible kidney transplantation: a multicenter study.
Orandi BJ; Garonzik-Wang JM; Massie AB; Zachary AA; Montgomery JR; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
Am J Transplant; 2014 Jul; 14(7):1573-80. PubMed ID: 24913913
[TBL] [Abstract][Full Text] [Related]
2. Incompatible live-donor kidney transplantation in the United States: results of a national survey.
Garonzik Wang JM; Montgomery RA; Kucirka LM; Berger JC; Warren DS; Segev DL
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2041-6. PubMed ID: 21784826
[TBL] [Abstract][Full Text] [Related]
3. Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation.
Motter JD; Jackson KR; Long JJ; Waldram MM; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen JR; Bozorgzadeh A; Gaber AO; Heher EC; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Massie AB; Segev DL; Garonzik-Wang JM
Am J Transplant; 2021 Apr; 21(4):1612-1621. PubMed ID: 33370502
[TBL] [Abstract][Full Text] [Related]
4. The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.
Axelrod D; Lentine KL; Schnitzler MA; Luo X; Xiao H; Orandi BJ; Massie A; Garonzik-Wang J; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Osama Gaber A; Montgomery RA; Segev DL
Am J Transplant; 2017 Dec; 17(12):3123-3130. PubMed ID: 28613436
[TBL] [Abstract][Full Text] [Related]
5. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.
Orandi BJ; Luo X; King EA; Garonzik-Wang JM; Bae S; Montgomery RA; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Osama Gaber A; Segev DL
Am J Transplant; 2018 Mar; 18(3):650-658. PubMed ID: 28834181
[TBL] [Abstract][Full Text] [Related]
6. Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
Jackson KR; Long J; Motter J; Bowring MG; Chen J; Waldram MM; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen J; Bozorgzadeh A; Gaber AO; Heher E; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Desai N; Massie AB; Segev DL; Garonzik-Wang J
Transplantation; 2021 Feb; 105(2):436-442. PubMed ID: 32235255
[TBL] [Abstract][Full Text] [Related]
7. A donor risk index for graft loss in pediatric living donor kidney transplantation.
Wasik HL; Pruette CS; Ruebner RL; McAdams-DeMarco MA; Zhou S; Neu AM; Segev DL; Massie AB
Am J Transplant; 2019 Oct; 19(10):2775-2782. PubMed ID: 30875148
[TBL] [Abstract][Full Text] [Related]
8. Desensitization outcomes: quantifying and questioning.
Cole E; Tinckam KJ
Am J Transplant; 2014 Jul; 14(7):1475-6. PubMed ID: 24912411
[No Abstract] [Full Text] [Related]
9. An economic assessment of contemporary kidney transplant practice.
Axelrod DA; Schnitzler MA; Xiao H; Irish W; Tuttle-Newhall E; Chang SH; Kasiske BL; Alhamad T; Lentine KL
Am J Transplant; 2018 May; 18(5):1168-1176. PubMed ID: 29451350
[TBL] [Abstract][Full Text] [Related]
10. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
Kwon H; Kim YH; Kim JY; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.
Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JSF; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG
Am J Transplant; 2018 Sep; 18(9):2274-2284. PubMed ID: 29464832
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation.
Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N
Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170
[TBL] [Abstract][Full Text] [Related]
13. Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.
Holscher CM; Luo X; Massie AB; Purnell TS; Garonzik Wang JM; Bae S; Henderson ML; Al Ammary F; Ottman SE; Segev DL
Am J Transplant; 2019 Jan; 19(1):269-276. PubMed ID: 30253051
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against ARHGDIB are associated with long-term kidney graft loss.
Kamburova EG; Gruijters ML; Kardol-Hoefnagel T; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Melchers RCA; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Bemelman FJ; Otten HG
Am J Transplant; 2019 Dec; 19(12):3335-3344. PubMed ID: 31194283
[TBL] [Abstract][Full Text] [Related]
15. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
16. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
[TBL] [Abstract][Full Text] [Related]
17. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
18. Positive Luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis.
Buttigieg J; Ali H; Sharma A; Halawa A
Nephrol Dial Transplant; 2019 Nov; 34(11):1950-1960. PubMed ID: 30508114
[TBL] [Abstract][Full Text] [Related]
19. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
Adebiyi OO; Gralla J; Klem P; Freed B; Davis S; Wiseman AC; Cooper JE
Am J Transplant; 2016 Dec; 16(12):3458-3467. PubMed ID: 27140940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
